Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Multiomic Analysis of Calf Muscle in Peripheral Artery Disease and Chronic Kidney Disease

ABSTRACT: Multiomic Analysis of Calf Muscle in Peripheral Artery Disease and Chronic Kidney Disease

PROVIDER: PRJNA1199364 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31749362_1.fastq.gz	Fastqsanger.gz
	SRR31749362_2.fastq.gz	Fastqsanger.gz
	SRR31749363_1.fastq.gz	Fastqsanger.gz
	SRR31749363_2.fastq.gz	Fastqsanger.gz
	SRR31749364_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Multiomic Analysis of Calf Muscle in Peripheral Artery Disease and Chronic Kidney Disease

Project description:This study examines the transcriptional profile at the single-nuclei resolution human gastrocnemius skeletal muscle from 20 patients with Peripheral artery disease (PAD) and 12 patients with both PAD and Chronic Kidney Disease (CKD). In all libraries, muscle specimens were pooled prior to nuclei isolations were performed.

2025-02-26 | GSE284482 | GEO

LncRNA expression profiling for 6 human monocytes samples from Coronary Artery Disease patients and non Coronary Artery Disease patients

Project description:The human LncRNA microarray analysis of the 6 monocytes samples from Coronary Artery Disease patients and non Coronary Artery Disease 3 Coronary Artery Disease patients and 3 non-Coronary Artery Disease donors

2015-06-05 | E-GEOD-69587 | biostudies-arrayexpress

Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes

Project description:Gene expression in peripheral blood is shown sufficient to differentiate patients with metabolic disorders from control. The signatures of metabolic syndrome, coronary artery disease and type 2 diabetes also have significant overlap. Microarrays were performed on 35 subjects in the following groups: control (n=9), rheumatoid arthritis (n=6), metabolic syndrome (n= 6), coronary artery disease (n=6) and type 2 diabetes (n=8). Intensity values for each array were normalized to a sum of 10,000.

2010-08-12 | E-GEOD-23561 | biostudies-arrayexpress

Integrated multiomic characterization of congenital heart disease

Project description:Integrated multiomic characterization of congenital heart disease

| PRJNA839343 | ENA

LncRNA expression profiling for 6 human plasma samples from Coronary Artery Disease patients and non Coronary Artery Disease patients

Project description:The human LncRNA microarray analysis of the 6 plasma samples from Coronary Artery Disease patients and non Coronary Artery Disease

2015-05-05 | GSE68506 | GEO

LncRNA expression profiling for 6 human monocytes samples from Coronary Artery Disease patients and non Coronary Artery Disease patients

Project description:The human LncRNA microarray analysis of the 6 monocytes samples from Coronary Artery Disease patients and non Coronary Artery Disease

2015-06-05 | GSE69587 | GEO

An integrative multiomic network model links the canonical lipid metabolism pathway to glucose regulation in coronary artery disease

Project description:An integrative multiomic network model links the canonical lipid metabolism pathway to glucose regulation in coronary artery disease

| PRJNA660471 | ENA

MicroRNA expression profiling for coronary artery calcification in Indian chronic kidney disease patients

Project description:Our study investigates the expression profilling of miRNAs in the pathogenesis of coronary artery calcification in chronic kidney disease patients and identify alter miRNA gene expression which will gives a unique platform for new drug discovery

2017-12-01 | GSE89699 | GEO

Effect of Disease and Exercise in Skeletal Muscle of Patients with Peripheral Artery Disease

Project description:Effect of Disease and Exercise in Skeletal Muscle of Patients with Peripheral Artery Disease

| PRJNA454312 | ENA

Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes

2010-08-12 | GSE23561 | GEO